CFDA Grants Innovative Product Status for MammaTyper
News Aug 23, 2016
BioNTech Diagnostics GmbH has announced that the Chinese FDA (CFDA) has granted the “Innovative Medical Product” status for MammaTyper®, a real time PCR kit for breast cancer stratification. This diagnostic product will undergo a special process designed by the CFDA to expedite the regulatory approval of innovative products.
MammaTyper® met the highly stringent criteria set by the CFDA for products entering the fast-track procedure. Since the program was initiated in March 2014, only ten in vitro diagnostics devices (IVD) have been granted access to the special approval process.
“We are very pleased that the CFDA has recognized the innovative and significant clinical value of
MammaTyper®,” stated Jay Z. Zhang, Chairman and CEO of Shuwen Biotech. “We will work closely with the CFDA towards an expedited approval to allow Chinese breast cancer patients to have full access to the clinical benefit of MammaTyper®.”
Dr. Sierk Poetting, CFO of BioNTech AG and Managing Director of BioNTech Diagnostics, commented: “This is a major milestone for MammaTyper® and we are very pleased with the CFDA’s recognition. We congratulate our colleagues at Shuwen for their accomplishment in obtaining the special approval process from the CFDA for MammaTyper®. We look forward to expanding the access to MammaTyper® to one of the largest populations in the world.”
The CE-IVD marked MammaTyper® test is a molecular diagnostic test for breast cancer stratification with FFPE tumor tissue samples. Based on precise measurements of gene expression by RNA analysis, MammaTyper® has the potential to significantly improve the standard of diagnosis and ultimately treatment of breast cancer patients.
Nano-tech Diagnostic Can Indicate Cancer or Thrombotic Risk in One Drop of BloodNews
A team of international researchers led by Professor Martin Hegner, Investigator in CRANN and Trinity’s School of Physics, have developed an automated diagnostic platform that can quantify bleeding – and thrombotic risks – in a single drop of blood, within seconds.READ MORE
High Fruit and Veg Consumption May Reduce Breast Cancer RiskNews
Women who eat a high amount of fruits and vegetables each day may have a lower risk of breast cancer, especially of aggressive tumors, than those who eat fewer fruits and vegetables, according to a new study led by researchers from Harvard T.H. Chan School of Public Health.READ MORE
Kidney Cancer Driver Could Lead to New Treatment StrategyNews
Scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change. Scientists have known this genetic change can lead to an overabundance of blood vessels, which help feed nutrients to the tumors. Their latest finding shows a potential new cancer-driving pathway.READ MORE